Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Lifshitz Law PLLC Announces Investigations of Vistagen Therapeutics, Inc. (NASDAQ: VTGN), CoreWeave, Inc. (NASDAQ: CRWV), Bath and Body Works, Inc. (NYSE: BBWI), and Ardent Health, Inc. (NYSE: ARDT)

accessnewswire.com
VTGN The company is under investigation for allegedly making materially false and misleading statements regarding its Phase 3 trial results for fasedienol, failing to disclose adverse facts and concealing material data. CRWV The company faces investigation for overstating its ability to meet customer demand and understating risks related to reliance on a single data center supplier, potentially impacting revenue. BBWI Investigation into allegations that the company's growth strategy was not effective, relied on collaborations to mask weak results, and was unlikely to meet financial guidance. ARDT The company is being investigated for overstating third quarter 2025 revenue and 2025 EBITDA guidance due to inadequate receivable collectability assessments and cost pressures.

NEW YORK CITY, NY / ACCESS Newswire / April 8, 2026 / Lifshitz Law Firm

Vistagen Therapeutics, Inc. (NASDAQ:VTGN)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company provided overwhelmingly positive statements to investors regarding the development and prospects of fasedienol, despite the fact that the Company's Phase 3 PALISADE‑3 trial of the investigational pherine candidate for the acute treatment of social anxiety disorder was beset by materially adverse facts; (ii) the Company disseminated false and misleading information and/or concealed material adverse data concerning the PALISADE‑3 study's design, execution, and clinical results; and (iii) as a result, the Company's statements about Vistagen's business, operations, and prospects were materially false and misleading at all relevant times.

If you are a VTGN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

CoreWeave, Inc. (NASDAQ:CRWV)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated CoreWeave's ability to meet customer demand for its service; (ii) the Company materially understated the scope and severity of the risk that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are a CRWV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Bath and Body Works, Inc. (NYSE:BBWI)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company's strategy of pursuing "adjacencies, collaborations and promotions" was not growing the customer base and/or delivering the level of growth in net sales touted; (ii) as the Company's strategy of "adjacencies, collaborations and promotions" faltered, the Company relied on brand collaborations "to carry quarters" and obfuscate otherwise weak underlying financial results; (iii) as a result, the Company was unlikely to meet its own previously issued financial guidance; and (iv) that, as a result of the foregoing, the Company's positive statements about Bath and Body Works's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are a BBWI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Ardent Health, Inc. (NYSE:ARDT)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Ardent Health's third quarter 2025 revenue was overstated due to inadequate determinations of accounts receivable collectability following the Company's transition to a new revenue accounting system and "recently completed hindsight evaluations of historical collection trends"; (ii) the Company's 2025 EBITDA guidance was overstated and would be reduced by $57.5 million at the midpoint, or approximately 9.6%, due to "persistent industry-wide cost pressures," including "payer denials"; and (iii) as a result, the Company's statements about Ardent Health's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you are an ARDT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email:[email protected]

SOURCE: Lifshitz Law Firm